stella
beta
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) — Stella
Recruiting
Back to Low Grade Ovarian Serous Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
United States
OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma
View full record on ClinicalTrials.gov